Press Releases

Date Title and Summary Additional Formats
Toggle Summary New C1™ Open App™ Program
Program enables researchers to develop new single-cell applications on the C1&#8482 Single-Cell Auto Prep
View HTML
Toggle Summary Fluidigm Ships Flex Six™ Integrated Fluidic Circuits
Fluidigm Ships Flex six™ Integrated Fluidic Circuits to Genotyping and Gene Expression Customers   SOUTH SAN FRANCISCO, Calif., June 3, 2014 — Fluidigm Corporation (NASDAQ:FLDM) has begun shipping production volumes of its Flex Six™ integrated fluidic circuits (IFCs) to genotyping and gene
View HTML
Toggle Summary Fluidigm At BofA Merrill Lynch 2014 Healthcare Conference
Fluidigm to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference   SOUTH SAN FRANCISCO, Calif. – May 6, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced that Chief Financial Officer Vikram Jog and Vice President of Corporate Development Un Kwon-Casado will present at the
View HTML
Toggle Summary Fluidigm Reports Q1 2014 Results
Q1 2014 organic revenue growth of 58% year-over-year
View HTML
Toggle Summary Fluidigm To Announce Q1 2014 Financial Results
Fluidigm to Announce Q1 2014 Financial Results and Host Conference Call for Investors   SOUTH SAN FRANCISCO, Calif., April 23, 2014 — Fluidigm Corporation (NASDAQ:FLDM) will report its first quarter 2014 financial results on May 5, 2014, after close of market.
View HTML
Toggle Summary Strong Revenue For Q4 - Full Year 2013 Revenue Up 36%
For Immediate Release
View HTML
Toggle Summary Fluidigm at the Cowen and Co. Annual Health Care Conference
Fluidigm to Present at the Cowen and Company 34th Annual Health Care Conference   SOUTH SAN FRANCISCO, Calif. – Feb. 26, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced that it will present at the Cowen and Company 34th Annual Health Care Conference in Boston, on Tuesday, March 4, 2014,
View HTML
Toggle Summary Fluidigm Completes Acquisition Of DVS Science
High-Parameter Single-Cell Protein Analysis Platform Joins With Industry-Leading...
View HTML
Toggle Summary Strong Revenue For Q4 - Full Year 2013 Revenue Up 36%
Fluidigm Reports Strong Revenue for Q4 and the Full Year 2013 - Full Year 2013 Revenue Up 36%   SOUTH SAN FRANCISCO, Calif. – February 6, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the fourth quarter and full year ended December 31, 2013.
View HTML
Toggle Summary Pricing Of $175 Million Convertible Senior Notes Offering
Fluidigm Announces Pricing of $175 Million Convertible Senior Notes Offering   SOUTH SAN FRANCISCO, CALIFORNIA, – January 30, 2014 – Fluidigm Corporation (NASDAQ: FLDM), a supplier of microfluidic systems for growth markets in the life science and agricultural biotechnology industries, today
View HTML